OCULAR THERAPEUTIX, INC — Investor Relations & Filings
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company's primary focus is on transforming the treatment of retinal diseases, such as wet age-related macular degeneration (wet AMD), a leading cause of blindness. Ocular Therapeutix utilizes its proprietary hydrogel-based drug delivery platform, ELUTYX™, to develop sustained-release therapies. This technology is designed to reduce the therapeutic burden on patients by decreasing the frequency of required treatments. The company's lead product candidate, AXPAXLI™ (axitinib intravitreal implant), is in late-stage clinical development for major retinal diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| OWNERSHIP DOCUMENT | 2025-02-14 | English | |
| OWNERSHIP DOCUMENT | 2025-02-14 | English | |
| OWNERSHIP DOCUMENT | 2025-02-05 | English | |
| Regulatory Filings 2025 | 2025-02-04 | English | |
| Regulatory Filings 2025 | 2025-01-31 | English | |
| OWNERSHIP DOCUMENT | 2024-11-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
5 filings
| |||||
| 12122743 | OWNERSHIP DOCUMENT | 2025-02-14 | English | ||
| 12122746 | OWNERSHIP DOCUMENT | 2025-02-14 | English | ||
| 12122748 | OWNERSHIP DOCUMENT | 2025-02-05 | English | ||
| 12122749 | Regulatory Filings 2025 | 2025-02-04 | English | ||
| 12122750 | Regulatory Filings 2025 | 2025-01-31 | English | ||
|
2024
10 filings
| |||||
| 12122751 | OWNERSHIP DOCUMENT | 2024-11-27 | English | ||
| 12122755 | OWNERSHIP DOCUMENT | 2024-11-27 | English | ||
| 12122753 | OWNERSHIP DOCUMENT | 2024-11-27 | English | ||
| 12122756 | OWNERSHIP DOCUMENT | 2024-11-27 | English | ||
| 12122760 | Regulatory Filings 2024 | 2024-11-26 | English | ||
| 12122758 | Regulatory Filings 2024 | 2024-11-26 | English | ||
| 12122757 | Regulatory Filings 2024 | 2024-11-26 | English | ||
| 12122762 | Regulatory Filings 2024 | 2024-11-25 | English | ||
| 12122761 | Regulatory Filings 2024 | 2024-11-25 | English | ||
| 12122763 | SC 13G/A | 2024-11-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
OCULAR THERAPEUTIX, INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31615/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31615 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31615 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31615 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31615}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OCULAR THERAPEUTIX, INC (id: 31615)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.